P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-β

被引:100
作者
Tai, Leon M. [1 ]
Loughlin, A. Jane [1 ]
Male, David K. [1 ]
Romero, Ignacio A. [1 ]
机构
[1] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England
基金
英国医学研究理事会;
关键词
Alzheimer's disease; amyloid beta; BCRP; blood-brain barrier; P-gp; DRUG EFFLUX TRANSPORTERS; BARRIER; CLEARANCE; LOCALIZATION; TRANSCYTOSIS; ENDOCYTOSIS; RECEPTORS; BINDING; CELLS; MODEL;
D O I
10.1038/jcbfm.2009.42
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clearance of amyloid beta (A beta) from the brain represents a novel therapeutic target for Alzheimer's disease. Conflicting data exist regarding the contribution of adenosine triphosphate-binding cassette transporters to the clearance of Ab through the blood-brain barrier. Therefore, we investigated whether Ab could be a substrate for P-glycoprotein (P-gp) and/or for breast cancer resistance protein (BCRP) using a human brain endothelial cell line, hCMEC/D3. Inhibition of P-gp and BCRP increased apical-to-basolateral, but not basolateral-to-apical, permeability of hCMEC/D3 cells to I-125 A beta 1- 40. Our in vitro data suggest that P-gp and BCRP might act to prevent the blood-borne A beta 1- 40 from entering the brain. Journal of Cerebral Blood Flow & Metabolism (2009) 29, 1079-1083; doi:10.1038/jcbfm.2009.42; published online 15 April 2009
引用
收藏
页码:1079 / 1083
页数:5
相关论文
共 16 条
[1]   P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model [J].
Cirrito, JR ;
Deane, R ;
Fagan, AM ;
Spinner, ML ;
Parsadanian, M ;
Finn, MB ;
Jiang, H ;
Prior, JL ;
Sagare, A ;
Bales, KR ;
Paul, SM ;
Zlokovic, BV ;
Piwnica-Worms, D ;
Holtzman, DM .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3285-3290
[2]   Localisation of breast cancer resistance protein in microvessel endothelium of human brain [J].
Cooray, HC ;
Blackmore, CG ;
Maskell, L ;
Barrand, MA .
NEUROREPORT, 2002, 13 (16) :2059-2063
[3]   β-Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1 [J].
Giri, R ;
Shen, YM ;
Stins, M ;
Yan, SD ;
Schmidt, AM ;
Stern, D ;
Kim, KS ;
Zlokovic, B ;
Kalra, VK .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 279 (06) :C1772-C1781
[4]  
Hardy J, 2006, J ALZHEIMERS DIS, V9, P151
[5]   Functional characterization of the brain-to-blood efflux clearance of human amyloid-β peptide (1-40) across the rat blood-brain barrier [J].
Ito, Shingo ;
Ohtsuki, Sumio ;
Terasaki, Tetsuya .
NEUROSCIENCE RESEARCH, 2006, 56 (03) :246-252
[6]   MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-β peptides -: Implications for the mechanisms of Aβ clearance at the blood-brain barrier [J].
Kuhnke, Diana ;
Jedlitschky, Gabriele ;
Grube, Markus ;
Krohn, Markus ;
Jucker, Mathias ;
Mosyagin, Igor ;
Cascorbi, Ingolf ;
Walker, Lary C. ;
Kroemer, Heyo K. ;
Warzok, Rolf W. ;
Vogelgesang, Silke .
BRAIN PATHOLOGY, 2007, 17 (04) :347-353
[7]   β-Amyloid efflux mediated by p-glycoprotein [J].
Lam, FC ;
Liu, RH ;
Lu, PH ;
Shapiro, AB ;
Renoir, JM ;
Sharom, FJ ;
Reiner, PB .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (04) :1121-1128
[8]   Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools [J].
Lichtlen, Peter ;
Mohajeri, M. Hasan .
JOURNAL OF NEUROCHEMISTRY, 2008, 104 (04) :859-874
[9]   Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases [J].
Löscher, W ;
Potschka, H .
PROGRESS IN NEUROBIOLOGY, 2005, 76 (01) :22-76
[10]   Human blood-brain barrier receptors for Alzheimer's amyloid-β 1-40 -: Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer [J].
Mackic, JB ;
Stins, M ;
McComb, JG ;
Calero, M ;
Ghiso, J ;
Kim, KS ;
Yan, SD ;
Stern, D ;
Schmidt, AM ;
Frangione, B ;
Zlokovic, BV .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :734-743